Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 1,326 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Validation Clear all
Recruiting No phase listed Observational

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

NCT06141993
View directory record Official record
Conditions
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic, Castration-resistant Prostate Cancer
Interventions
Not listed
Lead sponsor
Duke University
Other
Eligibility
18 Years and older · Male only
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
3
States / cities
New York, New York • Durham, North Carolina • Madison, Wisconsin
Source: ClinicalTrials.gov public record
Updated Nov 6, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Completed Not applicable Interventional Accepts healthy volunteers Results available

Design Validation of Senofilcon A With New UV-blocking Additive

NCT03707821
View directory record Official record
Conditions
Visual Acuity
Interventions
senofilcon A TEST Lens, senofilcon A CONTROL Lens
Device
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Industry
Eligibility
18 Years to 49 Years
Enrollment
253 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018
U.S. locations
10
States / cities
Cupertino, California • Maitland, Florida • Tallahassee, Florida + 7 more
Source: ClinicalTrials.gov public record
Updated Dec 5, 2019 · Synced Nov 15, 2026, 2:24 PM EST
Enrolling by invitation No phase listed Observational Accepts healthy volunteers

CSS-SR Validation Study

NCT06798493
View directory record Official record
Conditions
Complex Regional Pain Syndrome, Pain
Interventions
Complex Regional Pain Syndrome (CRPS) Severity Score - Self Report
Other
Lead sponsor
Hospital for Special Surgery, New York
Other
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2026
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Feb 13, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Active, not recruiting Phase 2 Interventional

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

NCT01334021
View directory record Official record
Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
Interventions
Biopsy, Conventional Surgery, Genetic Testing
Procedure · Other
Lead sponsor
M.D. Anderson Cancer Center
Other
Eligibility
18 Years and older · Female only
Enrollment
1,100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2026
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Sep 18, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Completed Not applicable Interventional Accepts healthy volunteers

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

NCT04679532
View directory record Official record
Conditions
Sweat Analysis
Interventions
Gx sweat patch, Reference sweat patch
Other
Lead sponsor
PepsiCo Global R&D
Industry
Eligibility
18 Years to 40 Years · Male only
Enrollment
65 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
1
States / cities
Walnut Creek, California
Source: ClinicalTrials.gov public record
Updated Jun 23, 2022 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational

GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients

NCT03635606
View directory record Official record
Conditions
Coronary Artery Disease
Interventions
Not listed
Lead sponsor
Sapere Bio
Industry
Eligibility
40 Years and older
Enrollment
370 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2023
U.S. locations
3
States / cities
Newport Beach, California • Baltimore, Maryland • Raleigh, North Carolina
Source: ClinicalTrials.gov public record
Updated Apr 4, 2023 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational

Validation of a Revised Food Frequency Questionnaire

NCT02693184
View directory record Official record
Conditions
Osteoporosis, Nutrition
Interventions
Full length Block 2014 Food Frequency Questionnaire, Revised Calcium, Vitamin D and Protein Screener
Other
Lead sponsor
University of Nebraska
Other
Eligibility
65 Years and older
Enrollment
31 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2018
U.S. locations
1
States / cities
Omaha, Nebraska
Source: ClinicalTrials.gov public record
Updated Sep 29, 2023 · Synced Nov 15, 2026, 2:24 PM EST
Completed Not applicable Interventional

Vascular Anomaly Pathology and Genomics Biopsy Study

NCT04836884
View directory record Official record
Conditions
Vascular Malformations, Vascular Anomaly, Hemangioma, Arteriovenous Malformations, Venous Malformation, Klippel Trenaunay Syndrome, Lymphatic Malformation
Interventions
Percutaneous Vascular Anomaly/Malformation Biopsy
Procedure
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
3 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Apr 21, 2022 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational Accepts healthy volunteers

Hydration Monitor Validation in Elderly

NCT02206633
View directory record Official record
Conditions
Dehydration
Interventions
Hydration Monitor
Device
Lead sponsor
Artann Laboratories
Industry
Eligibility
65 Years and older
Enrollment
73 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2015
U.S. locations
1
States / cities
Boone, North Carolina
Source: ClinicalTrials.gov public record
Updated Jun 23, 2015 · Synced Nov 15, 2026, 2:24 PM EST
Withdrawn No phase listed Observational Accepts healthy volunteers

abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies

NCT04442932
View directory record Official record
Conditions
Allergy, Allergic Asthma, Allergy to Cats, Allergy to House Dust, Allergy to Dog Dander, Allergy Cockroach
Interventions
Blood Collection
Device
Lead sponsor
Abionic SA
Industry
Eligibility
6 Years and older
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
5
States / cities
Washington D.C., District of Columbia • Baltimore, Maryland • Crownsville, Maryland + 1 more
Source: ClinicalTrials.gov public record
Updated Oct 5, 2020 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational Accepts healthy volunteers

SpO2 Accuracy Validation of the OxySoft Sensor Via Reference CO-Oximetry Motion Study

NCT04559763
View directory record Official record
Conditions
Hypoxia, Desaturation of Blood
Interventions
Non-Invasive Controlled Hypoxia, Introduction of Motion conditions: tapping or rubbing
Device · Other
Lead sponsor
Medtronic - MITG
Industry
Eligibility
18 Years to 50 Years
Enrollment
16 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020
U.S. locations
1
States / cities
Louisville, Colorado
Source: ClinicalTrials.gov public record
Updated Oct 22, 2020 · Synced Nov 15, 2026, 2:24 PM EST
Active, not recruiting No phase listed Observational

LITMUS Imaging Study

NCT05479721
View directory record Official record
Conditions
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
Interventions
Not listed
Lead sponsor
University of Oxford
Other
Eligibility
18 Years to 100 Years
Enrollment
450 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2025
U.S. locations
1
States / cities
San Antonio, Texas
Source: ClinicalTrials.gov public record
Updated Apr 16, 2025 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational

Stockholm3 Validation Study in a Multi-Ethnic Cohort

NCT04583072
View directory record Official record
Conditions
Prostate Cancer (Diagnosis)
Interventions
The Stockholm3 test
Diagnostic Test
Lead sponsor
Karolinska Institutet
Other
Eligibility
45 Years to 75 Years · Male only
Enrollment
2,152 participants
Timeline
2019 – 2023
U.S. locations
13
States / cities
Los Angeles, California • Palo Alto, California • Chicago, Illinois + 4 more
Source: ClinicalTrials.gov public record
Updated Oct 21, 2024 · Synced Nov 15, 2026, 2:24 PM EST
Withdrawn Not applicable Interventional Accepts healthy volunteers

Estimating Blood [Lactate] Non-Invasively

NCT05036122
View directory record Official record
Conditions
Healthy
Interventions
LabClasp
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Healthy volunteers
Accepts healthy volunteers
Timeline
2026
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Mar 12, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Not listed Not applicable Interventional

Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction

NCT05049070
View directory record Official record
Conditions
Refractive Errors
Interventions
Mobile medical application to self administer a subjective refraction test, Standard of care refraction test
Diagnostic Test
Lead sponsor
1800 Contacts, Inc.
Industry
Eligibility
18 Years to 39 Years
Enrollment
349 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
12
States / cities
Beverly Hills, California • Petaluma, California • Pomona, California + 9 more
Source: ClinicalTrials.gov public record
Updated Apr 6, 2023 · Synced Nov 15, 2026, 2:24 PM EST
Terminated Not applicable Interventional

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

NCT04630431
View directory record Official record
Conditions
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions
Best Practice, Educational Intervention, Electronic Health Record Review, Patient Navigation, Questionnaire Administration
Other · Behavioral
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
590 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2022
U.S. locations
3
States / cities
Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jun 4, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational Accepts healthy volunteers

Clinical Validation of the Tiba Medical Ambulo 2400 ABPM According to the ISO 80601-2-30 Standard in Adults, Adolescents, and Children

NCT00944983
View directory record Official record
Conditions
Hypertension
Interventions
Not listed
Lead sponsor
Tiba Medical, Inc.
Industry
Eligibility
3 Years and older
Enrollment
105 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009
U.S. locations
1
States / cities
Memphis, Tennessee
Source: ClinicalTrials.gov public record
Updated May 7, 2014 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational Accepts healthy volunteers

Development and Validation of Harbinger Health Test for Early Cancer Detection

NCT05435066
View directory record Official record
Conditions
Cancer
Interventions
Harbinger Health Test
Diagnostic Test
Lead sponsor
Harbinger Health
Industry
Eligibility
20 Years to 79 Years
Enrollment
8,038 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2025
U.S. locations
128
States / cities
Daphne, Alabama • Anchorage, Alaska • Prescott Valley, Arizona + 93 more
Source: ClinicalTrials.gov public record
Updated Jul 29, 2025 · Synced Nov 15, 2026, 2:24 PM EST
Terminated Not applicable Interventional Accepts healthy volunteers Results available

Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial

NCT04277962
View directory record Official record
Conditions
Post Partum Hemorrhage, Blood Loss, Vaginal Bleeding, Vaginal Delivery
Interventions
Triton L and D system for estimation of blood loss at time of vaginal delivery
Device
Lead sponsor
The University of Texas Medical Branch, Galveston
Other
Eligibility
18 Years to 50 Years · Female only
Enrollment
11 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
1
States / cities
Galveston, Texas
Source: ClinicalTrials.gov public record
Updated Jun 18, 2023 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational

Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes

NCT03474003
View directory record Official record
Conditions
Kidney Transplantation
Interventions
No intervention
Other
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Other
Eligibility
18 Years and older
Enrollment
7,557 participants
Timeline
2002 – 2020
U.S. locations
3
States / cities
Baltimore, Maryland • Rochester, Minnesota • Richmond, Virginia
Source: ClinicalTrials.gov public record
Updated May 1, 2020 · Synced Nov 15, 2026, 2:24 PM EST
Completed Not applicable Interventional Results available

Patient Self-sampling of HPV to Screen for Cervical Cancer

NCT05600283
View directory record Official record
Conditions
Human Papilloma Virus
Interventions
Swab kit (COBAS HPV 4800 Assay -Evalyn brush), Clinician-collection of cervical sample for HPV testing
Diagnostic Test
Lead sponsor
Mayo Clinic
Other
Eligibility
25 Years to 65 Years · Female only
Enrollment
222 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2024
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jan 6, 2026 · Synced Nov 15, 2026, 2:24 PM EST
Not listed No phase listed Observational

CV-SQuISH-ED: Clinical Validation Study

NCT04933760
View directory record Official record
Conditions
Sepsis, Infection
Interventions
Cytovale IntellipSep test
Diagnostic Test
Lead sponsor
Cytovale, Inc.
Industry
Eligibility
18 Years and older
Enrollment
599 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
4
States / cities
Baton Rouge, Louisiana • Columbia, Missouri • Winston-Salem, North Carolina + 1 more
Source: ClinicalTrials.gov public record
Updated Mar 31, 2022 · Synced Nov 15, 2026, 2:24 PM EST
Completed No phase listed Observational

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

NCT03837327
View directory record Official record
Conditions
Adnexal Mass, Ovarian Cancer, Pelvic Mass
Interventions
Not listed
Lead sponsor
Venn Biosciences Corporation
Industry
Eligibility
18 Years and older · Female only
Enrollment
1,025 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2024
U.S. locations
10
States / cities
Los Angeles, California • San Jose, California • Sunnyvale, California + 7 more
Source: ClinicalTrials.gov public record
Updated Apr 23, 2024 · Synced Nov 15, 2026, 2:24 PM EST